October 8, 2012
MESSAGE FROM THE DIRECTOR
Stan Gerson, MD
We are two weeks away from the site visit and it is a buckle-down time for program leaders and core directors. More than 70 members and staff are directly involved in slides, updated databases and documents, logistics, and rehearsals. Our preparation will yield a very solid presentation of our center, programs and shared resources. Our review team is informed, and balanced. I expect a careful assessment and a fair review. If you have been asked to participate, you will receive instructions on agenda, decorum, and choreography next week.
Before I get back to work on the details and planning for the site visit, I would like to share two forward-looking thoughts. First, please consider applying to the Provocative Questions RFA that was recently reissued. Many of us are ideal respondents. Harold Varmus places a good deal of emphasis on this process, and as a center we will do well with a number of applications and perhaps a few awards. These topics represent a consensus of important areas of research. The links are below.
Second, I was recently asked about potential topics for the NCI to consider. These often lead to NCI workshops and even RFAs. I have four (derived from recent insights from program leaders) and would like your suggestions. My suggestions are:
* * * * * * *
Provocative Questions links:
Group A: Cancer Prevention and Risk
Group B: Mechanisms of Tumor Development or Recurrence
Group C: Tumor Detection, Diagnosis, and Prognosis
Group D: Cancer Therapy and Outcomes
Provocative Questions homepage: http://provocativequestions.nci.nih.gov/
CASE CCC IN THE NEWS
Minority Women with Breast Cancer
Research Highlights Move Toward Personalized Treatment in AML
Pediatric regimens may provide insight into treatment of adult ALL
Doris Duke Clinical Scientist Development Award
The Doris Duke Clinical Scientist Development Award provides grants to junior physician-scientists to facilitate their transition to independent clinical research careers. Pre-proposals are being sought from junior physician scientist faculty conducting clinical research in any disease area. It is recommended that applicants have significant research experience and strong publication records. The Clinical Scientist Development Award will not require institutional nomination in 2013.
Pre-Proposal Deadline: October 29
Call for Ideas: Stand Up To Cancer-St. Baldrick's Pediatric Translational Cancer Research Dream Team
Stand Up To Cancer (SU2C) and the St. Baldrick's Foundation, along with the American Association for Cancer Research (AACR), call upon members of the cancer community to contribute their ideas to the groundbreaking SU2C-St. Baldrick's Pediatric Translational Cancer Research Dream Team. Investigators are invited to submit ideas for translational cancer research projects that would address laboratory and clinical efforts that will lead to the therapeutic interventions for childhood cancers and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, synergistic Dream Team of expert investigators. The ideas should be based on perceived opportunities for success as well as high-priority areas with a critical need for rapid progress beyond current medical care. The collective ideas for Dream Team translational research projects suggested by the cancer community will assist the SU2C-St. Baldrick's Joint Scientific Advisory Committee in selecting the most promising ideas to be submitted as full research proposals. The committee will select a SU2C-St. Baldrick's Pediatric Translational Cancer Research Dream Team from the invited proposals.
Please note that in this call for ideas the AACR and St. Baldrick's are not accepting research proposals for grant funding. Rather, the AACR and St. Baldrick's are inviting ideas to be submitted in a Letter of Intent for the SU2C-St. Baldrick's Pediatric Dream Team Translational Cancer Research Grant. A subset of ideas will be selected for submission of full research proposals for further consideration.
Deadline: November 1
Limited Submission: Rita Allen Foundation Scholars Program
The Rita Allen Foundation Scholars Program provides grants to leading medical research institutions selected by the Rita Allen Foundation Scientific Advisory Committee and confirmed by the Rita Allen Foundation Board of Directors. The Scholars program supports research scientists in the early stages of their careers. Fields of research are analgesics, cancer, immunology and neurosciences. Candidates must have completed their training and provided persuasive evidence of distinguished achievement or extraordinary promise in research in of the relevant fields. Each institution may nominate ONE candidate.
Internal Deadline: November 26
DOD Breast Cancer Research Program
The Department of Defense Breast Cancer Research Program is accepting applications for the Postdoctoral Fellowship Award. This award supports exceptionally talented recent doctoral or medical graduates in their pursuit of innovative, high-impact breast cancer research during their postdoctoral training and allows them to obtain the necessary experience for an independent career at the forefront of breast cancer research. These individuals should be exceptionally talented scientists who have demonstrated that they are the "best and brightest" of their peers. Applicants for this award must exhibit a strong desire to pursue a career in breast cancer research.
Pre-Application Deadline: December 4
MARK YOUR CALENDARS
National GvHD Health Symposium
The Meredith A. Cowden Foundation, in collaboration with the Case CCC, Seidman Cancer Center, and Taussig Cancer Institute, presents the 2012 National GvHD Health Symposium at the Embassy Suites Cleveland-Rockside on November 2. This unique one-day conference, will consist of two-tracks- one designed for physicians and other health care professionals and one for bone-marrow transplant (BMT) survivors, their families and their caregivers. Both tracks will focus on cutting edge research and new treatments.
This year's conference will feature a poster session. The deadline submit abstracts has been extended to Tuesday, October 11, 2012 at 11:59 pm. Abstracts should be emailed to email@example.com. You will be notified October 20 whether your poster has been selected. The registration fee for invited presenters is complimentary, but advance registration is required.
NCI CANCER BULLETIN
October 2, 2012
Cancer Genetics Faculty Candidate Chalk Talk
Sequencing Data Interest Group (SDIG) Meeting
Radiation Oncology Grand Rounds
Hematology and Oncology Special Presentation
Innovative Science Discussion Group
Hematology/Oncology Fellows Conference/Curriculum Series
Taussig Cancer Institute Grand Rounds: Annual Bruell Lecture
Cancer Center Seminar Series
Molecular Biology and Microbiology Thesis Presentation
Cancer Center Research in Progress
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
ADDITIONAL UPCOMING SEMINARS & EVENTS
Ninth International Conference of the Society for Integrative Oncology
Biennial Science of Global Prostate Cancer Disparities conference
The Cancer Genome Atlas 2nd Annual Scientific Symposium: Enabling Cancer Research Through TCGA
American Society of Hematology (ASH) Annual Meeting
Pacific Symposium on Biocomputing 2013
PREVIOUSLY ANNOUNCED OPPORTUNITIES
American Cancer Society Area of Special Interest: The Role of Healthcare and Insurance in Improving Outcomes in Cancer Prevention, Early Detection and Treatment
Leukemia & Lymphoma Society Specialized Center of Research Program
NIH BULLETIN – Notices and Funding Opportunities
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to firstname.lastname@example.org.